Treace Medical Concepts I... (TMCI)
NASDAQ: TMCI
· Real-Time Price · USD
6.89
-0.06 (-0.86%)
At close: Aug 15, 2025, 3:59 PM
6.89
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
Treace Medical Concepts Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 213.75M | 210.82M | 209.36M | 202.86M | 198.53M | 196.03M | 187.12M | 174.68M | 166.97M | 154.99M | 141.84M | 125.51M | 114.07M | 104.76M | 94.42M | 85.08M | 77.73M | 64.82M |
Cost of Revenue | 42.5M | 41.64M | 41.09M | 39.33M | 38.38M | 37.27M | 35.18M | 33.45M | 32.08M | 29.7M | 27.16M | 23.73M | 21.35M | 20M | 17.83M | 16.6M | 15.27M | 13.41M |
Gross Profit | 171.25M | 169.18M | 168.26M | 163.53M | 160.16M | 158.76M | 151.94M | 141.22M | 134.89M | 125.29M | 114.67M | 101.78M | 92.72M | 84.75M | 76.59M | 68.48M | 62.47M | 51.41M |
Operating Income | -47.89M | -52.3M | -55.69M | -62.27M | -64.95M | -56.62M | -51.43M | -48.14M | -41.64M | -40.52M | -34.84M | -36.94M | -31.09M | -23.2M | -16.51M | -7.28M | -1.88M | 652K |
Interest Income | 3.58M | 4.18M | 4.88M | 5.69M | 6.19M | 6.78M | 6.73M | 5.41M | 4.26M | 2.43M | 958K | 568K | 153K | 28K | 18K | 14K | 9K | 6K |
Pretax Income | -49.18M | -52.99M | -55.74M | -61.52M | -63.68M | -54.75M | -49.53M | -47.66M | -42.27M | -47.23M | -42.81M | -45.02M | -39.31M | -27.16M | -20.55M | -11.37M | -7.6M | -4.49M |
Net Income | -49.18M | -52.99M | -55.74M | -61.52M | -63.68M | -54.75M | -49.2M | -46.42M | -41.85M | -46.81M | -43.65M | -46.78M | -40.25M | -28.1M | -20.55M | -11.53M | -7.76M | -4.65M |
Selling & General & Admin | 197.91M | 200.59M | 203.36M | 206.26M | 206.19M | 198.09M | 187.93M | 174.33M | 162.05M | 151.87M | 135.94M | 125.51M | 111.86M | 96.57M | 82.9M | 67.01M | 56.62M | 44.48M |
Research & Development | 21.23M | 20.89M | 20.59M | 19.53M | 18.92M | 17.29M | 15.44M | 15.04M | 14.49M | 13.94M | 13.58M | 13.21M | 11.95M | 11.39M | 10.2M | 8.75M | 7.72M | 6.28M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 95K | 223K | 223K | 178K | 80K | -46K | -46K | -1K | 2K | n/a | n/a | n/a | n/a |
Operating Expenses | 219.15M | 221.48M | 223.95M | 225.8M | 225.11M | 215.38M | 203.37M | 189.36M | 176.53M | 165.81M | 149.52M | 138.72M | 123.81M | 107.96M | 93.1M | 75.76M | 64.35M | 50.76M |
Interest Expense | 5.26M | 5.25M | 5.26M | 5.25M | 5.23M | 5.2M | 5.17M | 5.17M | 5.07M | 4.73M | 4.4M | 4.12M | 3.89M | 3.98M | 4.06M | 4.1M | 5.73M | 5.15M |
Selling & Marketing Expenses | 138.84M | 143.44M | 147.64M | 150.71M | 151.47M | 147.57M | 140.89M | 130.34M | 121.83M | 114.67M | 102.94M | 95.89M | 86.84M | 74.24M | 64.47M | 53.57M | 45.69M | 36.47M |
Cost & Expenses | 261.64M | 263.12M | 265.05M | 265.13M | 263.48M | 252.65M | 238.55M | 222.82M | 208.62M | 195.51M | 176.68M | 162.45M | 145.16M | 127.96M | 110.93M | 92.36M | 79.61M | 64.17M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -322K | -1.24M | -424K | -424K | 838K | 1.75M | 945K | 951K | 12K | -1.73M | -1.74M | -1.74M |
Shares Outstanding (Basic) | 63.01M | 62.66M | 62.34M | 62.23M | 62.08M | 61.79M | 61.7M | 61.56M | 61.38M | 58.72M | 55.56M | 55.43M | 55.31M | 54.83M | 53.62M | 52.77M | 49.19M | 50.46M |
Shares Outstanding (Diluted) | 63.01M | 62.66M | 62.34M | 62.23M | 62.08M | 61.79M | 61.7M | 61.56M | 61.38M | 58.72M | 55.56M | 55.43M | 55.31M | 54.83M | 53.62M | 52.77M | 49.19M | 50.46M |
EPS (Basic) | -0.79 | -0.85 | -0.9 | -0.99 | -1.02 | -0.88 | -0.8 | -0.76 | -0.71 | -0.82 | -0.78 | -0.84 | -0.73 | -0.52 | -0.39 | -0.22 | -0.16 | -0.1 |
EPS (Diluted) | -0.79 | -0.85 | -0.9 | -0.99 | -1.02 | -0.88 | -0.8 | -0.76 | -0.71 | -0.82 | -0.78 | -0.84 | -0.73 | -0.52 | -0.39 | -0.22 | -0.16 | -0.1 |
EBITDA | -34.49M | -38.77M | -42.07M | -48.33M | -51.1M | -42.58M | -37.74M | -36.72M | -32.54M | -38.32M | -35.45M | -38.59M | -33.37M | -22.28M | -15.81M | -6.65M | -1.11M | 1.68M |
EBIT | -43.92M | -47.74M | -50.49M | -56.28M | -58.45M | -49.55M | -44.36M | -42.48M | -37.2M | -42.5M | -38.42M | -40.91M | -35.42M | -23.18M | -16.49M | -9.01M | -3.62M | -1.09M |
Depreciation & Amortization | 9.43M | 8.97M | 8.42M | 7.95M | 7.36M | 6.97M | 6.62M | 6.28M | 6.02M | 5.54M | 4.32M | 3.17M | 2.05M | 899K | 682K | 614K | 760K | 1.02M |